Avid Bioservices Inc (CDMO)

[ku]

dia, I am not putting anybody down whether Dr. Garnik or PPHM executives. In a nut shell PPHM has the choice of ignoring potential partners, AA, BTD, etc and go it alone and try to succeed in the long run with the chance of being beaten by another big BP with new science (new immunotherapy drugs or gene therapy)or partner up and use the resources to move Bavi in many fronts. In my opinion focusing on Bavi for one indication as a result of low funding means getting bugged down for years and the way the science moves now a days that can be the begining of the end for a company.